Get started
Author

Róbert Halmosi

Observed names: Halmosi Robert, R HALMOSI, R Halmosi, R. Halmosi, Robert Halmosi
Institution: University of Pecs
ORCID: 0000-0002-6965-7743
Observed ORCID: 0000-0002-6965-7743
OpenAlex ID: A5014038176
Cardioprotection by resveratrol: A human clinical trial in patients with stable coronary artery disease
2012 · K. Magyar, R. Halmosi, et al. · Clinical Hemorheology and Microcirculation · 379
Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry
2018 · Marco Canepa, Candida Fonseca, et al. · JACC Heart Failure · 163
PDF
Effect of Poly(ADP-Ribose) Polymerase Inhibitors on the Ischemia-Reperfusion-Induced Oxidative Cell Damage and Mitochondrial Metabolism in Langendorff Heart Perfusion System
2001 · Halmosi Robert, Berente Zoltan, et al. · Molecular Pharmacology · 141
Cardioprotective Effect of Resveratrol in a Postinfarction Heart Failure Model
2017 · Adam Riba, Laszlo Deres, et al. · Oxidative Medicine and Cellular Longevity · 132
PDF
The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results
2021 · Roland Gal, Laszlo Deres, et al. · International Journal of Molecular Sciences · 129
PDF
In Vitro Antioxidant Properties of Pentoxifylline, Piracetam, and Vinpocetine
2002 · Beata Horvath, Zsolt Marton, et al. · Clinical Neuropharmacology · 94
PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats
2009 · E. Bartha, I. Solti, et al. · Cardiovascular Research · 67
Resveratrol Improves Heart Function by Moderating Inflammatory Processes in Patients with Systolic Heart Failure
2020 · Roland Gal, Laszlo Deres, et al. · Antioxidants · 63
PDF
Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction
2021 · Petar M. Seferović, Marija Polovina, et al. · European Journal of Heart Failure · 62
PDF
Prevention of Doxorubicin-Induced Acute Cardiotoxicity by an Experimental Antioxidant Compound
2004 · Peter Deres, Robert Halmosi, et al. · Journal of Cardiovascular Pharmacology · 61
PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3β pathway☆
2006 · Anita Palfi, Ambrus Toth, et al. · Journal of Molecular and Cellular Cardiology · 60
Resveratrol and beyond: The Effect of Natural Polyphenols on the Cardiovascular System: A Narrative Review
2023 · Roland Gál, Róbert Halmosi, et al. · Biomedicines · 58
PDF
Doxycycline protects against ROS-induced mitochondrial fragmentation and ISO-induced heart failure
2017 · Adam Riba, Laszlo Deres, et al. · PLoS ONE · 53
PDF
The Role of Akt and Mitogen-Activated Protein Kinase Systems in the Protective Effect of Poly(ADP-Ribose) Polymerase Inhibition in Langendorff Perfused and in Isoproterenol-Damaged Rat Hearts
2005 · Anita Pálfi, Ambrus Tóth, et al. · Journal of Pharmacology and Experimental Therapeutics · 47
Akt activation induced by an antioxidant compound during ischemia-reperfusion
2003 · Ambrus Toth, Robert Halmosi, et al. · Free Radical Biology and Medicine · 40
PARP-Inhibitor Treatment Prevents Hypertension Induced Cardiac Remodeling by Favorable Modulation of Heat Shock Proteins, Akt-1/GSK-3β and Several PKC Isoforms
2014 · Laszlo Deres, Eva Bartha, et al. · PLoS ONE · 39
PDF
Mitochondrial protective effects of PARP-inhibition in hypertension-induced myocardial remodeling and in stressed cardiomyocytes
2021 · K. Ordog, O. Horvath, et al. · Life Sciences · 36
PDF
Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol
2020 · Roland Gal, Dora Praksch, et al. · Cardiovascular Therapeutics · 29
PDF
PARP inhibition and postinfarction myocardial remodeling
2016 · Robert Halmosi, Laszlo Deres, et al. · International Journal of Cardiology · 28
A quinazoline-derivative compound with PARP inhibitory effect suppresses hypertension-induced vascular alterations in spontaneously hypertensive rats
2014 · Klara Magyar, Laszlo Deres, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 28
PDF
Regulation of Kinase Cascade Activation and Heat Shock Protein Expression by Poly(ADP-ribose) Polymerase Inhibition in Doxorubicin-induced Heart Failure
2011 · Eva Bartha, Izabella Solti, et al. · Journal of Cardiovascular Pharmacology · 28
Effect of L-2286, a Poly(ADP-ribose)polymerase Inhibitor and Enalapril on Myocardial Remodeling and Heart Failure
2008 · Eva Bartha, Gyongyi N Kiss, et al. · Journal of Cardiovascular Pharmacology · 28
Scavenger Effect of Experimental and Clinically Used Cardiovascular Drugs
2001 · Zsolt Marton, Robert Halmosi, et al. · Journal of Cardiovascular Pharmacology · 28
BGP‐15 Protects against Heart Failure by Enhanced Mitochondrial Biogenesis and Decreased Fibrotic Remodelling in Spontaneously Hypertensive Rats
2021 · Orsolya Horvath, Katalin Ordog, et al. · Oxidative Medicine and Cellular Longevity · 25
PDF
The Genetic Architecture of Hypertrophic Cardiomyopathy in Hungary: Analysis of 242 Patients with a Panel of 98 Genes
2022 · Róbert Sepp, Lidia Hategan, et al. · Diagnostics · 23
Works count: 79
Citation count: 2,062
H-index: 24
I10-index: 36
Year
Topic
Type